Detalhe da pesquisa
1.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Lancet Oncol
; 24(8): 925-935, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37541273
2.
Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum.
Oncologist
; 27(9): 768-777, 2022 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35762393
3.
Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial.
Oncologist
; 27(1): 22-29, 2022 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34523767
4.
Assessing cognitive toxicity in early phase trials - What are we missing?
Psychooncology
; 31(3): 405-415, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34651364
5.
Intermittent schedules of the oral RAF-MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study.
Lancet Oncol
; 21(11): 1478-1488, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33128873
6.
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
BMC Cancer
; 20(1): 1210, 2020 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33298007
7.
Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.
Oncology
; 90(5): 280-8, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27082424
8.
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.
BMC Cancer
; 21(1): 245, 2021 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33685408
9.
A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic.
Lancet Oncol
; 21(7): 889-891, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32615107
10.
Contrast Clearance Analysis (CCA) to Assess Viable Tumour following Stereotactic Radiosurgery (SRS) to Brain Metastasis in Non-Small Cell Lung Cancer (NSCLC).
Cancers (Basel)
; 16(6)2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38539550
11.
Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review.
EClinicalMedicine
; 64: 102228, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37781154
12.
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasets.
Mol Oncol
; 17(2): 230-237, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36269676
13.
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial.
Nat Med
; 29(10): 2577-2585, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37710001
14.
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.
Cell Rep Med
; 4(12): 101307, 2023 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38056464
15.
BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF(V600E) mutation.
Future Oncol
; 8(5): 499-507, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22646765
16.
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy.
PLoS One
; 17(7): e0270950, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35797413
17.
Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors.
Clin Lung Cancer
; 23(7): 571-577, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36085282
18.
A pilot of Blood-First diagnostic cell free DNA (cfDNA) next generation sequencing (NGS) in patients with suspected advanced lung cancer.
Lung Cancer
; 165: 34-42, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35085982
19.
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic Changes.
Mol Cancer Ther
; 21(6): 1020-1029, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35368084
20.
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
Eur J Cancer
; 171: 44-54, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35704974